Who
Robert Graham Susman
Director
Company insider
Files Form 4 as: Director, Immunovant.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $136K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 May 2025
- Last trade
- 1 May 2026
- Last filed
- 1 May 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 1 May 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $68K2,502 at $27.17 | filing |
| 1 May 2026filed 1 May 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $68K2,502 at $27.17 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —13,880 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,061 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,061 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —13,880 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | IMVT Immunovantoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,234 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | IMVT ImmunovantBiotechnology | SEC FORM 4 Code A | —25,016 at $0.00 | filing |
News
Immunovant (NASDAQ:IMVT) Insider Tuyl Christopher Van Sells 1,327 Shares of Company StockIMVT · themarketsdaily.com · 10 Oct 2026Immunovant (NASDAQ:IMVT) Stock: Insider Jay Stout Sells 3,809 SharesIMVT · themarketsdaily.com · 9 Oct 2026Immunovant (NASDAQ:IMVT) CEO Sells $119,589.66 in StockIMVT · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Robert Graham Susman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.